Data Sovereignty conference
We are pleased to invite you to a Data Sovereignty conference in the eHealth sector. We will pitch about our solutions and exhibit our products. The conference takes place on Thursday, February 17, 2022, 10:00 AM – 3:15 PM. Save the date and watch an online conference here.
Data Sovereignty conference in details
The event is organised under the patronage of the French Presidency of the Council of the European Union. As you can read on the organizer’s website, digital technology plays a critical role. It is changing the eHealth industry. Proven and safe technology is crucial in the healthcare services provision. Thus it is also crucial in the organization of the healthcare system. Data sovereignty allows value to be created from highly sensitive human data. Moreover it enables individuals to protect their data – at the same time. We will take part in two debates: ‘Data Sovereignty in Europe’ and ‘Data processing in Healthcare: Challenges, difficulties, forecasts’. Cancer Center will also take part in Healthcare startup contest.
Cancer Center exhition details
During the event Cancer Center’s CEO, Piotr Krajewski wil be talking about our solution for pathologist – PathoCam and PathoPlatform and radiologists – RadiologyPlatform.
Cancer Center has developed specialized AI algorithmic solutions to analyze medical images. Faster and better cancer diagnosis is now available . To clarify, we use deep learning (AI) technology to improve the cancer diagnosis process. Firstly, our solutions are both in API and Web Platforms. Secondly, they are designed to offer better access for second and third diagnostic opinions. Finally, Cancer Center helps to develop a therapeutic approach quickly. In short, this will help both the patients and physicians.
In addition, we support the digitization of pathological materials from the microscope. The daily work of a pathologist is significantly improved. PathoCam and PatoPaltform allows physician to analyze, annotate, and make the preparation available for a second opinion.